$37.07
1.403.92%
At close: Aug 14, 5:00 PM EST
$37.07
N/A
After Hours: Aug 14, 4:00 PM EST
Parabilis Medicines Inc (PBLS) Stock Price, Quote, News & History
PBLSNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Parabilis Medicines (PBLS) stock?
You can purchase shares of Parabilis Medicines (NASDAQ:PBLS) through any online brokerage.
Who are Parabilis Medicines (PBLS) competitors?
Other companies in Parabilis Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Parabilis Medicines (PBLS) stock?
Parabilis Medicines has a consensus price target of $41.67.
What is the current price for Parabilis Medicines (PBLS)?
The stock price for Parabilis Medicines (NASDAQ: PBLS) is $37.07 last updated August 14, 2026 at 4:00 PM EDT.
Does Parabilis Medicines (PBLS) pay a dividend?
There are no upcoming dividends for Parabilis Medicines.
When is Parabilis Medicines (NASDAQ:PBLS) reporting earnings?
Parabilis Medicines does not have any upcoming earnings scheduled.
Is Parabilis Medicines (PBLS) going to split?
There is no upcoming split for Parabilis Medicines.
What sector and industry does Parabilis Medicines (PBLS) operate in?
Parabilis Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
